ENTRY       D01684                      Drug
NAME        Ozagrel sodium (JP18);
            Ozapen (TN)
FORMULA     C13H11N2O2. Na
EXACT_MASS  250.0718
MOL_WEIGHT  250.2284
CLASS       Blood modifier agent
             DG01950  Antithrombotic agent
              DG01712  Antiplatelet agent
               DG01516  Thromboxane A2 synthase inhibitor
REMARK      Therapeutic category: 2190 3999
            Chemical structure group: DG01256
            Product (DG01256): D01683<JP> D01684<JP>
EFFICACY    Anticoagulant, Platelet aggregation inhibitor, Thromboxane A2 (TXA2) synthase inhibitor
TARGET      TBXAS1 (CYP5A1) [HSA:6916] [KO:K01832]
  PATHWAY   hsa00590(6916)  Arachidonic acid metabolism
            hsa04611(6916)  Platelet activation
INTERACTION  
STR_MAP     map07034  Eicosanoids
            map07049  Antithrombosis agents
BRITE       Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               219  Miscellaneous
                2190  Miscellaneous
                 D01684  Ozagrel sodium (JP18)
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D01684  Ozagrel sodium (JP18)
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01712  Antiplatelet agent
                DG01516  Thromboxane A2 synthase inhibitor
                 DG01256  Ozagrel
                  D01684  Ozagrel sodium
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Isomerases (EC5)
               Thromboxane-A synthase
                TBXAS1 (CYP5A1)
                 D01684  Ozagrel sodium (JP18) &lt;JP&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D01684  Ozagrel sodium
              D01684  Ozagrel sodium injection
              D01684  Ozagrel sodium for injection
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01712  Antiplatelet agent
                DG01516  Thromboxane A2 synthase inhibitor
                 DG01256  Ozagrel
DBLINKS     CAS: 189224-26-8
            PubChem: 7848747
            LigandBox: D01684
            NIKKAJI: J195.867D
ATOM        18
            1   N4y N    27.0331  -14.7865
            2   C8x C    27.4703  -16.1159
            3   C8x C    28.1700  -13.9527
            4   C1b C    25.8087  -14.0985
            5   N5x N    28.8697  -16.1159
            6   C8x C    29.3070  -14.7865
            7   C8y C    24.6075  -14.8216
            8   C8x C    24.6308  -16.2266
            9   C8x C    23.3772  -14.1393
            10  C8x C    23.4238  -16.9439
            11  C8x C    22.2229  -14.8155
            12  C8y C    22.2112  -16.2617
            13  C2b C    21.0042  -16.9788
            14  C2b C    19.7876  -16.2963
            15  C6a C    18.5882  -17.0089
            16  O6a O    17.3715  -16.3266 #-
            17  O6a O    18.6057  -18.4039
            18  Z   Na   14.9549  -16.2803 #+
BOND        18
            1     2   5 2
            2     3   6 2
            3     4   7 1
            4     7   8 2
            5     7   9 1
            6     8  10 1
            7     9  11 2
            8    10  12 2
            9    12  13 1
            10    5   6 1
            11   11  12 1
            12   13  14 2
            13   14  15 1
            14    1   2 1
            15   15  16 1
            16    1   3 1
            17   15  17 2
            18    1   4 1
///
